Integrated Quantitative Investments LLC Acquires New Position in Genpact Limited (NYSE:G)

Integrated Quantitative Investments LLC bought a new position in Genpact Limited (NYSE:G - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 18,900 shares of the business services provider's stock, valued at approximately $812,000.

A number of other institutional investors have also modified their holdings of the stock. Atlas Capital Advisors Inc. boosted its position in Genpact by 55.8% during the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock valued at $26,000 after acquiring an additional 216 shares in the last quarter. ExodusPoint Capital Management LP boosted its position in Genpact by 18.0% during the fourth quarter. ExodusPoint Capital Management LP now owns 177,671 shares of the business services provider's stock valued at $7,631,000 after purchasing an additional 27,044 shares in the last quarter. OneAscent Financial Services LLC grew its stake in Genpact by 52.9% in the fourth quarter. OneAscent Financial Services LLC now owns 13,085 shares of the business services provider's stock valued at $562,000 after purchasing an additional 4,526 shares during the last quarter. Bryce Point Capital LLC purchased a new position in Genpact in the fourth quarter valued at about $488,000. Finally, Trexquant Investment LP raised its holdings in Genpact by 177.3% in the fourth quarter. Trexquant Investment LP now owns 239,127 shares of the business services provider's stock worth $10,271,000 after purchasing an additional 152,905 shares in the last quarter. 96.03% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Genpact

In related news, SVP Piyush Mehta sold 12,000 shares of Genpact stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the transaction, the senior vice president now owns 151,182 shares in the company, valued at $6,475,125.06. The trade was a 7.35 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the transaction, the chief executive officer now owns 310,246 shares in the company, valued at $15,167,926.94. This represents a 4.20 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 2.80% of the company's stock.

Genpact Stock Performance

Shares of G stock traded down $1.96 during trading hours on Thursday, hitting $46.16. The company's stock had a trading volume of 315,920 shares, compared to its average volume of 1,350,831. The stock has a market cap of $8.11 billion, a PE ratio of 16.32, a price-to-earnings-growth ratio of 1.84 and a beta of 1.06. Genpact Limited has a 12-month low of $30.23 and a 12-month high of $56.76. The company has a 50 day moving average of $51.09 and a 200 day moving average of $45.67. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50.

Genpact (NYSE:G - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. On average, sell-side analysts forecast that Genpact Limited will post 3.21 EPS for the current fiscal year.

Genpact Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th were issued a $0.17 dividend. The ex-dividend date of this dividend was Tuesday, March 11th. This is an increase from Genpact's previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a yield of 1.47%. Genpact's payout ratio is presently 23.94%.

Analysts Set New Price Targets

A number of equities research analysts recently commented on G shares. Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and increased their target price for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. Needham & Company LLC increased their price objective on Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a report on Friday, February 7th. TD Cowen upgraded Genpact from a "hold" rating to a "buy" rating and boosted their target price for the stock from $45.00 to $60.00 in a research note on Friday, February 7th. Finally, Mizuho increased their price target on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Six equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $48.44.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.